Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Datz

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Alimentary Pharmacology & Therapeutics|October 4, 2014
Gender- and site-specific differences of colorectal neoplasia relate to vitamin DE Aigner, A Stadlmayr, U Huber-Schönauer, et al.
The Journal of Endocrinology|September 1, 1999
Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cellsM Lefebvre, B Paulweber, L Fajas, et al.
Journal of Internal Medicine|March 19, 2011
Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasiaA Stadlmayr, E Aigner, B Steger, et al.
Journal of Hepatology|February 12, 1998
Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosisC Datz, M R Lalloz, W Vogel, et al.
Journal of Internal Medicine|December 6, 2019
Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-upS Zandanell, M Strasser, A Feldman, et al.
Hepatology (Baltimore, Md.)|October 27, 2001
Combination of interferon induction therapy and ribavirin in chronic hepatitis CP Ferenci, H Brunner, K Nachbaur, et al.
European Journal of Gastroenterology & Hepatology|July 4, 2001
Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Austrian Hepatitis Study GroupP Ferenci, R Stauber, P Steindl-Munda, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2013
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis CA F Stättermayer, R Strassl, A Maieron, et al.
Diabetes & Metabolism|September 30, 2018
Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approachA Feldman, S K Eder, T K Felder, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 4, 2017
Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pyloriC Bilgilier, A Stadlmann, A Makristathis, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Alimentary Pharmacology & Therapeutics|October 4, 2014
Gender- and site-specific differences of colorectal neoplasia relate to vitamin DE Aigner, A Stadlmayr, U Huber-Schönauer, et al.
The Journal of Endocrinology|September 1, 1999
Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cellsM Lefebvre, B Paulweber, L Fajas, et al.
Journal of Internal Medicine|March 19, 2011
Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasiaA Stadlmayr, E Aigner, B Steger, et al.
Journal of Hepatology|February 12, 1998
Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosisC Datz, M R Lalloz, W Vogel, et al.
Journal of Internal Medicine|December 6, 2019
Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-upS Zandanell, M Strasser, A Feldman, et al.
Hepatology (Baltimore, Md.)|October 27, 2001
Combination of interferon induction therapy and ribavirin in chronic hepatitis CP Ferenci, H Brunner, K Nachbaur, et al.
European Journal of Gastroenterology & Hepatology|July 4, 2001
Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Austrian Hepatitis Study GroupP Ferenci, R Stauber, P Steindl-Munda, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2013
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis CA F Stättermayer, R Strassl, A Maieron, et al.
Diabetes & Metabolism|September 30, 2018
Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approachA Feldman, S K Eder, T K Felder, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 4, 2017
Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pyloriC Bilgilier, A Stadlmann, A Makristathis, et al.
Pageof 3